Our support centre

For further information please contact us from Mo – Fry 08:00 – 17:00

Ph.: +49 391 61 07 645    Mail: info@rehastim.de

 
 
< Meilenstein: FDA- Zulassung für RehaStim2
05.01.2012 11:42

FDA Approval for the RehaStim2

RehaStim2, the next Generation of Stimulation, now available in the US


HASOMED GmbH proudly announce FDA clearance of its breakthrough stimulator RehaStim2 for functional electrical stimulation in the USA.

The official paper can be found here

http://www.accessdata.fda.gov/cdrh_docs/pdf11/K112844.pdf <http://www.accessdata.fda.gov/cdrh_docs/pdf11/K112844.pdf>

 

RehaStim2 - the Next Generation FES

Apart from the modified appearance, the new stimulator RehaStim2 offers an even simpler operation.

Via a rotary knob, the existing eight stimulation channels are assigned and defined with corresponding parameters. On the large color display the user can navigate easily.

Color-coded channels for each muscle make it even easier and faster to applicate the electrodes. In the extended memory, over 100 patients combined with their training settings can be stored and the respective course of therapy can be saved.